Study links low-dose aspirin to less advanced colon, lung cancer

08/19/2013 | Reuters

An analysis of data on 80,000 cancer patients in Sweden showed that regular intake of low-dose aspirin was associated with less advanced disease and smaller tumors in patients with colon and lung cancer. However, the link was not seen in patients with prostate or breast cancer. The findings appear in the British Journal of Cancer.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT